BiomX Inc. (PHGE)
NYSEAMERICAN: PHGE · Real-Time Price · USD
0.8754
-0.1646 (-15.83%)
At close: Jun 2, 2026, 4:00 PM EDT
0.8375
-0.0379 (-4.33%)
Pre-market: Jun 3, 2026, 5:12 AM EDT
BiomX Market Cap
BiomX has a market cap or net worth of $8.88 million as of June 2, 2026. Its market cap has decreased by -37.16% in one year.
Market Cap
8.88M
Enterprise Value
7.71M
1-Year Change
-37.16%
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since July 17, 2019, BiomX's market cap has decreased from $1.93B to $8.88M, a decrease of -99.54%. That is a compound annual growth rate of -54.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 8.88M | 211.13% |
| Dec 31, 2025 | 2.85M | -78.49% |
| Dec 31, 2024 | 13.27M | 3.09% |
| Dec 29, 2023 | 12.87M | 130.01% |
| Dec 30, 2022 | 5.60M | -87.59% |
| Dec 31, 2021 | 45.11M | -69.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intensity Therapeutics | 11.63M |
| Jupiter Neurosciences | 11.39M |
| BioVie | 11.24M |
| Immuron | 11.04M |
| Ernexa Therapeutics | 10.64M |
| Kairos Pharma | 10.58M |
| BioCardia | 10.46M |
| BioRestorative Therapies | 10.35M |